Functional characterization of Trip10 in cancer cell growth and survival

Chia-Chen Hsu1, Yu-Wei Leu, Min-Jen Tseng

  • 1Human Epigenomics Center, Department of Life Science, Institute of Molecular Biology and Institute of Biomedical Science, National Chung Cheng University, Chia-Yi, Taiwan.

Abstract

Insights

Trip10 (also known as CIP4) DNA methylation differs across cancers. Hypermethylation in brain and breast tumors may promote cancer, while hypomethylation in liver cancer suggests a tumor suppressor role for Trip10.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cdc42-interacting protein-4, Trip10 (CIP4), is a multi-domain adaptor protein with tissue-specific functions.
  • Trip10 is highly expressed in ER+ breast cancer; its depletion increases DNA methylation.
  • Hypothesized Trip10 acts as a tumor suppressor in ER- breast cancer and is epigenetically regulated by DNA methylation in other cancers.

Purpose of the Study:

  • To investigate the epigenetic regulation of Trip10 by DNA methylation in liver, brain, ovarian, and breast cancers.
  • To evaluate the role of Trip10 as a tumor suppressor or oncogene in different cancer types.

Main Methods:

  • Methylation-specific polymerase chain reaction and bisulfite sequencing were used to assess Trip10 DNA methylation.
  • Trip10 was overexpressed to study its effects on cell colony formation and in vivo tumorigenesis.

Main Results:

  • Trip10 was hypermethylated in brain tumors and breast cancer, but hypomethylated in liver cancer.
  • Overexpression of Trip10 promoted colony formation and tumorigenesis in brain tumor (IMR-32) cells.
  • Overexpression of Trip10 suppressed colony formation and tumorigenesis in ovarian cancer (CP70) cells.

Conclusions:

  • Trip10's role in cancer cell growth and death is cancer-type specific.
  • Differential DNA methylation of Trip10 can promote cell survival or cell death depending on the cell type.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...